-
(7a,17b) -7- (9-Bromononyl) -estra-1,3,5 (10) -triene-3,17-diol 17-acetate CAS NO.875573-66-3
Aha ngwaahịa:(7a,17b) -7- (9-Bromononyl) -estra-1,3,5 (10) -triene-3,17-diol 17-acetate
CAS NO:875573-66-3
Ụdị okwu:
Ndị na-emekọ ihe ọnụ -5;
Estra-1,3,5 (10) -triene-3,17-diol,7- (9-broMononyl) -, 17-acetate, (7a,17b) -;
(7R,8R,9S,13S,14S,17S)-7-(9-Bromonyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17- decaid
Ụdị emetụtara:FULLVESTRANT INTERMEDIATES;Ndị na-ahụ maka ọgwụ;kemikal intermediates;akụrụngwa akụrụngwa na etiti
-
(7alpha,17beta) -17- (Acetyloxy) -7- (9-bromononyl) estr-4-en-3-otu CAS NO.875573-63-0
Aha ngwaahịa:(7alpha,17beta) -17- (Acetyloxy) -7- (9-bromononyl) estr-4-en-3-otu;
CAS NO:875573-63-0
Ụdị okwu:
FULLVESTRANT INTERMEDIATES–4(N-4);
(7a,17b) -17-Acetyloxy-Estra-4-Ene- 7- (9-Bromononyl) -3-Otu;
Ụdị emetụtara:Ndị nọ n'etiti R&D ọgwụ;FULVESTRANT INTERMEDIATES
-
trans-4-Dimethylaminocrotonic acid hydrochloride CAS NO.848133-35-7
Aha ngwaahịa:trans-4-Dimethylaminocrotonic acid hydrochloride
CAS NO:848133-35-7
Ụdị okwu:
Afatinib etiti;
Afatinibint-2Trans-4-Dimethylaminocrotonicacidhydrochloride;
2-Butenoicacid, 4- (dimethylamino) -, (2E) -, hydrochloride;
Ụdị emetụtara:mgbochi ọrịa kansa;Crotonic acid;Afatinib na ndị etiti ya;Ndị na-ahụ maka ọgwụ;API etiti
-
3- (4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl) piperidine-2,6-dione CAS NO.827026-45-9
Aha ngwaahịa:3- (4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl) piperidine-2,6-dione
CAS NO:827026-45-9
Ụdị okwu:
Lenalidomide etiti;
2,6-Piperidinedione,3- (1,3-dihydro-4-nitro-1-oxo-2H-isoindol-2-yl)
4-Nitro LenalidoMide;
3-dihydro-4-nitro-1-oxo-2H-isoindol-2-yl)-;
6-Piperidinedione;
Ụdị emetụtara:Bromobenzyls;aromatic hydrocarbons;ndị etiti;intermediates ọgwụ;lenalidomide intermediates;
-
tert-butyl 4- (6-aminopyridin-3-yl) piperazine-1-carboxylate CAS NO.571188-59-5
Aha ngwaahịa:tert-butyl 4- (6-aminopyridin-3-yl) piperazine-1-carboxylate.
CAS NO:571188-59-5
Ụdị okwu:1-BOC-4-(6-AMINOPYRIDIN-3-YL)PIPERAZINE;
OTAVA-BB1207229;
4- (6-Aminopyridin-3-yl) piperazine-1-carboxylicacidtert-butylester;
PALBOCICLIB 4;
PALBOCICLIB etiti
Ụdị emetụtara:piperazine;palbociclib intermediates;intermediates ọgwụ
-
4-chloro-7-Methoxyquinoline-6-carboxaMide CAS NO.417721-36-9
Aha ngwaahịa:4-chloro-7-Methoxyquinoline-6-carboxaMide
CAS NO:417721-36-9
Ụdị okwu:6-QuinolinecarboxaMide,4-chloro-7-Methoxy-;
Lenvatinib adịghị ọcha b;
Lenvatinib etiti
Ụdị emetụtara:Heterocycles;ihe nrụtụ aka-adịghị ọcha;lenvatinib etiti;intermediates ọgwụ;ngwaahịa - ngwaahịa ọgwụ;kemikal intermediates;
-
4-Amino-3-chlorophenol hydrochloride CAS NO.52671-64-4
Aha ngwaahịa:4-Amino-3-chlorophenol hydrochloride
Ọ BỤGHỊ:52671-64-4
Ụdị okwu:
2-chloro-4-hydroxyanilinehydrochloride;
lenvatinib etiti;
Ụdị emetụtara:Halides;ihe mgbochi ụlọ organic;general reagents;etiti nke lenvatinib;etiti
-
(S) -N4- (3-chloro-4-fluorophenyl) -7- (tetrahydrofuran-3-yloxy) quinazoline-4,6-diaMine CAS NO.314771-76-1
Aha ngwaahịa:(S)-N4-(3-chloro-4-fluorophenyl)-7- (tetrahydrofuran-3-yloxy) quinazoline-4,6-diaMine
CAS NO:314771-76-1
Ụdị okwu:
Afatinib etiti;
Afatirib-1;
4-QuinazolinaMine, N- (3-chloro-4-fluorophenyl) -6-amine-7-[[(3S) -tetrahydro-3-furanyl] oxy] -;
6-Amino-4-[(3-chloro-4-fluorophenyl) amino] -7-[[(S) -tetrahydro-3-furanyl] oxy] quinazoline;
Ụdị emetụtara:Ndị etiti;mgbochi tumor;ihe nrụtụ aka-ihe nrụtụ aka adịghị ọcha;kemikal intermediates;ihe ọkọlọtọ;mgbochi ọrịa cancer;afatinib nwoke;afatinib intermediates;intermediates ọgwụ;
-
2-Amino-N- (2-chloro-6-methylphenyl) thiazole-5-carboxamide CAS NO.302964-24-5
Aha ngwaahịa:2-Amino-N- (2-chloro-6-methylphenyl) thiazole-5-carboxamide
CAS NO:302964-24-5
Ụdị okwu:
Dasatinib adịghị ọcha2;
Dasatinib etiti
5-ThiazolecarboxaMide,2-aMino-N- (2-chloro-6-Methylphenyl);
Ụdị emetụtara:ọgwụ anticancer Dasatinib intermediates;ọgwụ ọhụrụ na ọgwụ jeneriki;kemikal intermediates;
-
![N- (2-Chloro-6-methylphenyl) -2-[(6-chloro-2-methyl-4-pyrimidinyl) amino]-5-thiazolecarboxamide CAS NO.302964-08-5](//cdn.globalso.com/shlzpharma/118.png)
N- (2-Chloro-6-methylphenyl) -2-[(6-chloro-2-methyl-4-pyrimidinyl) amino]-5-thiazolecarboxamide CAS NO.302964-08-5
Aha ngwaahịa:N- (2-Chloro-6-methylphenyl) -2-[(6-chloro-2-methyl-4-pyrimidinyl) amino]-5-thiazolecarboxamide
CAS NO:302964-08-5
Ụdị okwu:
Dasatinib etiti
2- ((6-Chloro-2-methylpyrimidin-4-yl) amino)-N- (2-chloro-6-methylphenyl) thiazole-5-carboxamide 95%;
Ụdị emetụtara:ọgwụ anticancer Dasatinib intermediates;ọgwụ ọhụrụ na ọgwụ jeneriki;kemikal intermediates;
-
![5-[4- ((3-Chloro-4- ((3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde CAS NO.231278-84-5](//cdn.globalso.com/shlzpharma/117.png)
5-[4- ((3-Chloro-4- ((3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde CAS NO.231278-84-5
Aha ngwaahịa:5-[4- ((3-Chloro-4- ((3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde
CAS NO:231278-84-5
Ụdị okwu:
Lapatinib etiti
Ụdị emetụtara:Lapatinib di-p-toluenesulfonate, API etiti;ndị etiti;lapatinib n'etiti anọ;lapatinib etiti;lapatinib;intermediates ọgwụ
-
2-Formylfuran-5-boronic acid CAS NO.27329-70-0
Aha ngwaahịa:2-Formylfuran-5-boronic acid
Ọ BỤGHỊ:27329-70-0
Ụdị okwu:
TIMTEC-BB SBB004171;
5-FORMYL-2-FURANBORONIC Acid;
Ụdị emetụtara:Boronic acid na usoro ya;boric acid;intermediates ọgwụ;API etiti;lapatinib;lapatinib etiti;ndị etiti;mgbochi ọrịa cancer;lapatinib C2;ọgwụ adịghị ọcha na etiti
![N- (2-Chloro-6-methylphenyl) -2-[(6-chloro-2-methyl-4-pyrimidinyl) amino]-5-thiazolecarboxamide CAS NO.302964-08-5](http://cdn.globalso.com/shlzpharma/118.png)
![5-[4- ((3-Chloro-4- ((3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde CAS NO.231278-84-5](http://cdn.globalso.com/shlzpharma/117.png)
